BCL9 and Familial prostate cancer: Moreover, it was observed that the higher expression of BCL9 was correlated with shorter biochemical recurrence-free survival (P = 0.037) as indicated by Kaplan-Meier survival analysis.393 Detailed mechanism of the BCL9-mediated prostate cancer progression is yet to be elucidated.